Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Gilteritinib
Gilteritinib
1254053-43-4
|
552.354
|
2.271
Gilteritinib is a potent selective inhibitor of both of the mutations, internal tandem duplication and tyrosine kinase domain, of the FLT3 receptor. It is used to treat relapsed or refractory acute myeloid leukemia.
ASP-2215 | gilteritinib
Gilteritinib is a potent selective inhibitor of both of the mutations, internal tandem duplication and tyrosine kinase domain, of the FLT3 receptor. It is used to treat relapsed or refractory acute myeloid leukemia.
ASP-2215 | gilteritinib
$41/5 mg
(EBC)
1
We provide 0 compound for Gilteritinib
Powered by Bioz